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Abstract 
When judging a population’s health to determine disability-adjusted life years, disability weight 
is a tool for measuring the severity of disability caused by a disease. However, previous studies 
have pointed out that surveys targeting ordinary citizens produce unclear disability weight values. 
Therefore, in an attempt to obtain clearer estimations, we conduct a paper-based questionnaire 
survey of medical professionals—nurses with over ten years of experience—believed to have 
extensive knowledge of diseases and experience in patient care. We find that disability weight 
estimations based on the survey of medical professionals presents higher values than those based 
on a survey of ordinary citizens using the same estimation approach, especially for non-terminal-
stage diseases. This suggests that medical-professionals-based surveys may correct the 
underestimated disability weights of non-terminal diseases (e.g., early stage of cancers and 
mellitus) found through ordinary-citizens-based surveys. Moreover, we illustrate that depressive 
disorder and early-stage cancers have almost the same health loss since their disability weights 
are similar. While regulating policy, it is recommended that more attention be paid to non-
terminal diseases and depression. 
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When measuring a population’s health status, the concept of disability-adjusted life years utilizing 
disability weights is adopted by global health organizations worldwide (Murray, Lopez and World 
Health Organization, 1996; Murray et al., 2012; Salomon et al., 2012). An example of this 
application is the Global Burden of Disease (GBD) project, which provides a list of health loss 
severities due to different diseases, injuries, and other risk factors worldwide, with disability 
weights as the key factors (Murray et al., 2012; Salomon et al., 2012). A disability weight 
expresses the severity of disability caused by a disease scaled between 0 and 1, where 0 equals 
perfect health and 1 is equivalent to death. 
  Previous studies have established an empirical evaluation of disability weights based on a 
worldwide survey (Murray et al., 1996; Jelsma et al., 2000; Brennan et al., 2007; Yoon et al., 
2007; Basiri et al., 2008; Hong and Saver, 2009; Lai, Habicht and Kiivet, 2009; Lyons et al., 2011; 
Van Spijker et al., 2011; Salomon et al., 2015). Murray et al. (1996) and Salomon et al. (2012, 
2015) focus on a global evaluation of disability weights, whereas other studies focus on specific 
countries and areas. Disability weight evaluations for developed countries include those of 
Brennan et al. (2007) for Australia, Yoon et al. (2007) for South Korea, Lyons et al. (2011) for the 
United Kingdom, and Van Spijker et al. (2011) for the Netherlands. Aside from those of developed 
countries, studies focusing on developing countries have accumulated in recent years. These 
include Basiri et al. (2008) for Iran and Jelsma et al. (2000) who compare global disability weights 
to those weights from Zimbabwe participations. 
For the disability evaluation method, existing literature uses the following main approaches to 
measure individual or social preferences. The approaches include paired comparison (Salomon et 
al. 2012, 2015), visual analog scale (van Spijker et al., 2011; Baltussen et al. 2002; Murray et al., 
1996), and person-trade-off (Murray et al., 1996; Yoon et al., 2007; Salomon et al., 2012, 2015). 
The paired comparison method entails comparing the severity of health loss among multiple 
paired diseases. It requires the respondents to choose the healthier individual between two 
hypothetical individuals with different health states (Salomon et al., 2012). The visual analog 
scale consists of respondents evaluating health states by assigning a value to each health state, 
where 0 represents the worst state of health and 10 or 100 represents the best state of health 
(Baltussen et al., 2002). The person-trade-off method consists of asking the respondents how 
many outcomes of a particular state of health they consider equivalent to outcomes of another 
state of health (Nord, 1995). It is believed that the person-trade-off approach is preferable because 
it represents the social preferences better than individual preferences (Van Spijker et al., 2011). 
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Samolom et al. (2012) combined paired comparison approach with health population equivalence, 
which is based on the person-trade-off approach. Please see Haagsma et al. (2014) for a detailed 
review. 
Among the disability weight studies, the methodology adopted in the GBD 2010 project is 
representative and this valuation method and the results thereof were published by Salomon et al. 
(2012). For example, in Japan, Nomura et al. (2017) evaluate overall population health based on 
the disability weights reported in Salomon et al. (2015), using the same methodology used in 
Salomon et al. (2012). However, the validity of the disability weights is argued by later scholars 
(Taylor et al., 2013; Nord, 2013). Nord (2013) argues that the measurement of disability weights 
based on the method proposed in Salomon et al. (2012) has pointed out that the disability weights 
of some diseases (e.g., deafness) are relatively small, which might be caused by the survey sample 
containing participants that likely consider the deafness patients to be living with mild disability. 
When the targeted participants who thought the diseases were not in poor health, then the 
disability weight value may become small, and vice versa.   
Further, disability weight studies have found that surveys based on the general public and those 
based on medical professionals produce different disability weight values (Jelsma et al., 2000; 
Baltussen et al., 2002). Baltussen et al. (2002) investigate disability weights of nine diseases 
between lay people and medical professionals in rural Burkina Faso in Africa through a survey 
of 37 lay people and 17 medical professionals. It was found that the disability weights from 
medical professionals were lower than those from lay people, establishing the disability weight 
from medical professionals as the proxy of general public. Similarly, Jelsma et al. (2000) 
compared the disability weights from medical professionals, non-professionals, and global burden 
diseases. They concluded that the weights of diseases’ severity are highly correlated with the 
global burden diseases. However, medical professionals record much lower weights than non-
professional Zimbabweans in a survey of 12 medical professionals and 58 non-professionals. The 
reason the disability weight from medical professionals is higher than that from non-professionals 
could be that the medical care system in rural Africa is underdeveloped or that the local residents 
or lay people are concerned about the limited access to medical services. However, existing 
literature has so far focused on developing nations and studies focused on Japan are scarce. 
Therefore, a survey targeting medical professionals and results comparison may provide 
insightful evidence to clarify this phenomenon. Moreover, well-experienced nurses might have a 
neutral judgment of health loss caused by diseases than doctors and the public. Nursing is defined 
4 
 
as “the protection, promotion, and optimization of health and abilities, prevention of illness and injury, 
facilitation of healing, alleviation of suffering through the diagnosis and treatment of human response, 
and advocacy in the care of individuals, families, groups, communities, and populations” (American 
Nurses Association, 2015, p.1). Therefore, nurses can be considered appropriate for assessing the 
impact of illness on people's lives. 
  In this study, we aim to estimate the disability weights of 17 diseases in Japan based on the 
original survey conducted for this study in 2018 using a methodology adopted by the World 
Health Organization and published in the Lancet (Salomon et al., 2012). The targeted participants 
of the survey are medical professionals (nurses) who work in national or public university 
hospitals and have more than 10 years of nursing experience. As argued above, the estimation of 
disease disability weights based on a survey of ordinary citizens may include unclear values due 
to participants’ knowledge gap of the diseases. Thus, the results derived in this study are expected 
to provide clearer disability weight estimates, insightful evidence for measuring health loss more 
accurately, and the implications for related policies. 
The outline of this paper is as follows: Sections 2.1 and 2.2 provide the materials and 
methodology, respectively. The empirical results are summarized in Section 4, and Section 5 
presents the conclusion.  
 
2. Methodology 
2.1 Materials and Design 
To investigate the disability weights of diseases, we conducted a paper-based survey in Japan in 
December 2018. In a bid to overcome the unclear results derived from surveys based on medical 
specialists and ordinary citizens, the participants of the current survey included (randomly selected) 
nurses only. A purposive sampling technique was utilized to select targeted respondents with extensive 
knowledge of the diseases. More precisely, the questionnaires were sent to the nursing directors of all 
42 national university hospitals and all 8 public university hospitals. Each nursing director circulated 
the questionnaires to nurses with more than 10 years working experience (30 nurses for each national 
university hospital and 20 nurses for public university hospitals). In total, 1,420 questionnaires were 
mailed to the targeted hospitals and 294 responses were collected, representing a response rate of 21%.  
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  The respondents were informed about the study’s purpose, method, voluntary participation, and 
anonymity of information and the study was approved by the Research Ethics Committee of the 
Graduate School of Medicine, The University of Tokyo (No. 2018068NI). In the questionnaire, the 
respondents were asked the following question: “After reading the instruction of this survey, are you 
still willing to participate in this research analysis?” to which the responses were either 1, which 
equaled “agree”, or 2, “disagree”. Of the 294 respondents, eight declined participation in the 
measurement of disability weight research or were missing, while the rest consented to having their 
answers included in the analysis. Therefore, 286 observations are included in our analysis. 
  When measuring the disability weights, we followed the extensive methodology proposed by 
Salomon et al. (2012) to design the questionnaire for collecting information on paired comparisons 
and population health equivalence. The survey included seventeen representative diseases like cancer, 
stroke, and lifestyle diseases. These entailed six types of ‘cancers’ (stomach cancer, three forms of 
bowel cancer, and two of lung cancer), four types of adult disease (including two forms of diabetes, 
high blood pressure, and hyperlipidemia), four types of stroke, two types of mental disease that 
disturb daily life (Alzheimer's and dementia, and depression), and chronic kidney disease 
(requiring dialysis). We focused only on these important diseases to keep the respondents’ burden 
of answering the survey at a minimum.  
  The key aspects of the questionnaire used for measuring the disability weight of each disease, paired 
comparison and population health equivalence, were designed as follows. For paired comparisons, the 
nurses were asked 17 questions, the first of which, for example, was, “Compared to early stomach 
cancer, which diseases would you rather suffer from? Please select from the list below,” followed by 
a list of the other 16 diseases1. It should be noted that respondents who were missing and there were 
                                                     
1 Early colorectal cancer; Terminal colorectal cancer; Early lung cancer; Terminal lung cancer; 
Acute myocardial infarction; Stroke: long-term consequences, agnosia (or aphasia); Stroke: long-
term consequences, hemiplegia; Stroke: long-term consequences, persistent consciousness disorder; 
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no choices in the choice list might be the same. To distinguish between the two situations, we added 
an option in the list that states that “none of the above 16 diseases are preferable”. In total, 171 paired 
comparisons were obtained.  
  Regarding population health equivalence, for each disease, the respondents were asked to select the 
overall health benefit that they believe to be equivalent to the presented hypothetical health policy. 
The questions were posed, for example, as follows: “Policy A, which prevented 1000 people from 
getting an illness that causes rapid death, has the same population health benefit as   ”, then the 
respondents were asked to select either “(1) less than 1000; (2) 1500; (3) 2000; (4) 3000; (5) 5000; or 
(6) more than 10000 people prevented from getting Early stomach cancer.” The population range, 
from less than 1000 to more than 10000 people, represented the options of the overall health benefit 





Figure 1. Number of population on the number line of population health equivalence. 
  
After deleting the observation of missing key information, the total number of observations obtained 
were 286 for paired comparison and 253 for population health equivalence. Moreover, the 
demographic characteristics of the respondents were included in the survey. These included age, 
gender, type of qualification, length of experience, position, marital status, number of children, highest 
education level achieved by the respondent, respondent’s (and their parents and partner’s) yearly 
income, household income, volunteer experience within one year, health status, consumption on health 
                                                     
Diabetes mellitus: with insulin injection; Diabetes mellitus: without insulin injection; High blood 
pressure; Dyslipidemia; Alzheimer dementia; Depressive disorder; Chronic renal failure: dialysis. 
1000 1500 2000 3000 5000 10000 0 
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status, periodic medical examination, and other medical/health-related questions. 
 
 
2.2 Empirical strategy 
 
For each participant, the disability weights of the diseases are computed according to the paired 
disease comparison and population health equivalence categories following Salomon et al. (2012). 
In the case of the paired comparisons, we apply a probit regression that was utilized in the analysis 
of discrete choice experimental data in Salomon et al. (2012), whereas for the population health 
equivalence, the interval regression is adopted2.   
  For the paired comparisons, we regard the selected choice between the diseases as the 
dependent variable. Furthermore, we treat the 17 diseases as independent variables and create 
dummy variables from them. The binary choice variable 𝑌 = 1 when the comparison health 
states3 are considered healthier compared to the primary health state. Thus, 𝑃(𝑌 = 1|𝑋) = Φ(𝑋′𝛽),                         (1) 
where Φ is the cumulative distribution function of the standard normal distribution, 𝑃 denotes 
the probability, and the matrix 𝑋 is the disease indicator, and 𝛽 is a set of parameters estimated 
from the maximum likelihood. Following Salomon et al. (2012), the disease indicators are 
selected as independent variables and the respondents’ socioeconomic factors are not included in 
the probit regression. 
The population health equivalence questions provide insight on tradeoffs between mortality 
and nonfatal outcomes, which is needed to anchor the results from the probit regression analysis 
(Eq.1) of the paired comparisons onto the disability weight scale (0,1). Because the population 
health equivalence questions are framed in terms of a binary comparison between an intervention 
that averted 1000 fatalities and another intervention that averted some number of nonfatal 
                                                     
2 It is thought that the interval regression is appropriate in this study. The population health 
equivalence portion of the paper-based survey is structures as a categorized choice, which is left-
censored at 1250; 1250-1750; 1750-2500; 2500-4000; 4000-7500; and right-censored at a value 
of 7500. On the contrary, in Salomon et al. (2012), the population health equivalence portion of 
the survey consists of a randomly chosen value for the participants. 
3 The paired comparison occurs with one of the 16 diseases when one of the diseases is selected as 
the base disease. 
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outcomes, responses provide interval-censored information rather than exact values4. Therefore, 𝐿 = 𝑍′𝜃 + 𝜀,                                (2) 
where 𝐿 is a logit-transformed variable of the interval population health equivalence of diseases 
following Salomon et al. (2012). 𝐿 is logit transformed unobserved continuous outcomes is in 
the observed interval from population health equivalence. That is, it is left-censored at a value of 
1250 in the population health equivalence measurement—1250-1750, 1750-2500, 2500-4000, 
4000-7500—and right-censored at a value of 75005. A detailed description of the transformation 
is shown in the Appendix. The matrix 𝑍 represents the dummy variables of the diseases. The 
parameters of diseases 𝜃 , estimated by maximum likelihood, represent the logit-transformed 
disability weights. Thus, ?̂? = 𝛼0 + 𝛼𝜃 + 𝜇,                           (3) 
where ?̂? is the parameter of the 17 diseases from Eq. (1) estimated by the maximum likelihood, 
whereas 𝜃 represents the parameters estimated by Eq. (2) using an interval regression. 𝛼0 and 𝛼 are the parameters estimated by ordinary least squares. 𝜇 is the error term.  
The regression results in an estimated slope and intercept, which are then used for predicting 
the probit coefficients and transforming them onto the (logit) disability-weight scale (Eq.3), as 
well as for the numerical integration of the obtained disability weights estimates on the natural 0-
to-1 scale (Eq.4). First, we simulate the normal random variates on the logit scale with the means 
of each disease predicted from Eq. (3) and the variance defined by the overall standard deviation 
of these coefficients across survey-specific estimates from Eq. (2). Next, we transform each of 
these simulated values through an inverse-logit function (Eq.4). Finally, we compute the mean 
across the resulting values for each disease. Therefore, we simulate the disability weight 𝑤 of 
the 17 diseases by predicting the dependent variable ?̂? in Eq. (3), which we rescale from 0 to 1, 
as in Eq. (4). Therefore,  𝑤 = 𝑒𝐾1+𝑒𝐾,                                  (4) 
where 𝑤 denotes the disability weight of diseases, 𝐾 is the prediction of the dependent 
variable ?̂? based on Eq. (3), and 𝑒𝐾 is the natural exponential function. All statistical analyses 
are performed using Stata MP 16.0 software (StataCorp, College Station, TX, USA). 
                                                     
4 Furthermore, due to this study using paper-based questions rather than web-based one, the current 
analysis method is different from that of Salomon et al. (2012). 
5 For example, the independent variables with logit-transformed values of 1250, 1750, 2500, 4000, 





Table 1 displays the characteristics of the respondents, who are skilled nurses with over 10 years 
of working experience in hospitals. As expected, 89% of the nurses are women, whereas 7% of 
the nurses are men. Because our survey targets experienced nurses, only 42% of the nurses are 
younger than 45 years. Regarding appointment, 9% and 41% of the respondents hold the position 
of director or nurse manager, respectively. The other nurses include assistant nurse 
manager/charge nurse; staff and other positions share around 50% of the sample. 
 
 
Table 1. Characteristics of the medical professionals 
Variables Obs. Percent 
Gender     
  Male 20 7% 
  Female 255 89% 
 unknown 11 4% 
Age     
  31–35 29 10% 
  36–40 47 16% 
  41–45 46 16% 
  46–50 59 21% 
  51–55 53 19% 
  56–60 49 17% 
  unknown 3 1% 
Clinical experience years     
  –10 4 1% 
  11–15 61 21% 
  16–20 45 16% 
  21–25 36 13% 
  26–30 62 22% 
  31–35 55 19% 
  36– 20 7% 
  unknown 3 1% 
Appointment     
  Director 27 9% 
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Table 1. continued.   
Nurse manager 116 41% 
Assistant nurse manager/charge nurse 80 28% 
Staff 59 21% 
The other positions 2 1% 
unknown 2 1% 
Total 286   
Note: Observations of paired comparison: 286; observations of population health equivalence: 253.  
 
Table 2 displays the estimation results of the disability weights of the 17 diseases. The estimated 
disability weights of the diseases range between 0.346 and 0.605, which indicates that the nurses 
believe that these diseases have a strong influence on health. The lowest estimated disability 
weight is that of high blood pressure, sitting at 0.346, whereas the highest disability weight is that 
of terminal lung cancer, sitting at 0.605. Intuitively, in terms of disability-adjusted life years, 
terminal lung cancer indicates a high level of health loss, meaning patients may be disabled to 
the extent that they cannot live without various assistants. Similarly, such high levels of disability 
are more likely to result from other terminal cancers, stroke with serious sequelae, stroke with 
long-term consequences, and chronic renal failure with dialysis. On the contrary, low disability 
weights appear for high blood pressure, diabetes mellitus with/without insulin injection, and 
dyslipidemia. However, these diseases are thought to have negative influences on lives as the 
weight ranges between 0.346 and 0.453.  
 The measurement of disability weight provides an illustration of health loss due to diseases and 
the comparisons of disease severities. For example, based on the estimation, depressive disorder 
has a disability weight of 0.498 and ranks at 13 as shown in Table 2. Similarly, health losses from 
early stomach, lung, and colorectal cancers are 0.500, 0.518, and 0.520, respectively. This result 
illustrates that depressive disorder and early cancers have almost the same health loss. This may 
provide insightful evidence for using the comparison between the early stages of stomach, 
colorectal, and lung cancers to understand patients’ health losses due to depressive disorder. The 
results suggest that patients with depressive disorders might need more attention or aid from the 
government or health organizations regarding their resultant disabilities. 
Table 3 presents comparisons between the disability weight results of this study (derived from 
Table 2) and those of a representative previous study; that is, Salomon et al. (2015), which has 
been adopted by the World Health Organization and Japan (Nomura et al., 2017). This aims to 
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show the differences in the disability weights found when the participants are medical 
professionals rather than ordinary citizens so as to correct any unclear values resulting from 
ordinary citizens’ lack of disease knowledge or experience. Where the categories of the diseases 











Lower bound Upper bound 
Early stomach cancer  0.500 0.148 0.852 12 
Terminal stomach cancer 0.577 0.230 0.924 4 
Early colorectal cancer 0.520 0.166 0.875 10 
Terminal colorectal cancer 0.599 0.250 0.949 2 
Early lung cancer 0.518 0.164 0.872 11 
Terminal lung cancer 0.605 0.268 0.943 1 
Acute myocardial infarction 0.546 0.200 0.892 8 
Stroke: long-term consequences, agnosia (or  0.550 0.207 0.893 7 
   aphasia)         
Stroke: long-term consequences, hemiplegia 0.573 0.228 0.917 5 
Stroke: long-term consequences, persistent 
consciousness disorder 0.597 0.251 0.943 3 
Diabetes mellitus: with insulin injection  0.453 0.104 0.801 14 
Diabetes mellitus: without insulin injection 0.385 0.052 0.717 15 
High blood pressure 0.346 0.019 0.672 17 
Dyslipidemia 0.367 0.037 0.696 16 
Alzheimer’s and dementia 0.536 0.189 0.882 9 
Depressive disorder 0.498 0.146 0.851 13 
Chronic renal failure: dialysis 0.570 0.228 0.912 6 










Table 3: Comparison of disability weights between current estimation and previous study 
Health state Disability weight Disability weight 
     (Salomon et al. 2015) 
Early stomach cancer  0.500 
0.288 Early colorectal cancer 0.520 
Early lung cancer 0.518 
Terminal stomach cancer 0.577 
0.54 Terminal colorectal cancer 0.599 
Terminal lung cancer 0.605 
Acute myocardial infarction 0.546 0.422 
Stroke: long-term consequences, hemiplegia 0.573 0.070 
Stroke: long-term consequences, agnosia (or aphasia) 0.550 0.316 
Stroke: long-term consequences, persistent 
consciousness disorder 
0.597 0.588 
Diabetes mellitus: with insulin injection  0.453 0.020 or 0.133  
Diabetes mellitus: without insulin injection 0.385 0.020 or 0.133  
Alzheimer’s and dementia 0.536 0.377 
Depressive disorder 0.498 0.396 
Chronic renal failure: dialysis 0.570 0.571 
Note: In Salomon et al. (2015) Table 2, for acute myocardial infarction for days 1-2, the disability weight 
is 0.432, whereas for days 3-28, it is 0.074. For stroke, the weight of long-term consequences, mild case is 
0.019; long-term consequences, moderate case is 0.070; long-term consequences, moderate, plus cognition 
problems is 0.316; long-term consequences severe is 0.552; and long-term consequences, severe, plus 
cognition problems is 0.588. Diabetic foot is 0.020, and diabetic neuropathy is 0.133. Major depressive 
disorder (moderate episode) is 0.396. End-stage renal disease on dialysis is 0.571. Neurological disorders 
of dementia (moderate) is 0.377. Cancer (diagnosis and primary treatment) is 0.288; Metastatic is 0.451 





disease description and consequences. Column 1 displays the disability weights derived from 
Table 2, whereas Column 2 summarizes the disability weights from Salomon et al. (2015). 
The results are as follows: we find that the estimated disability weights based on a survey of 
well-experienced nurses vary from those in Salomon et al. (2015), which are based on a survey 
of ordinary citizens, despite using the same estimation approach. With regard to the 15 
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corresponding diseases covered in both studies, the overall results of the current study show 
higher disability weights than those estimated in previous studies (see Table 3). These results 
suggest that ordinary citizens underestimate the health loss caused by the diseases compared to 
nurses. This may be because ordinary citizens have less knowledge about or experience with 
diseases compared to well-experienced medical professionals. 
Regarding serious diseases, we find slight differences and even consistencies between the 
disability weights found in the current estimations and those found in the previous study. For 
example, the disability weight of chronic renal failure: dialysis in this study is 0.570, whereas in 
previous studies, the disability weight of this condition was 0.571. Similarly, for stroke: long-
term consequences, persistent consciousness disorder, we found a slight difference. We estimated 
the disability weight of this disease at 0.597, whereas the corresponding disability weight in the 
previous study was 0.588. These relatively small differences are also found among the terminal 
cancers. 
  In contrast, the estimated disability weights of early- and middle-stage diseases based on the 
current survey are higher than those of the previous survey. For example, we find the disability 
weights of early stomach cancer, early colorectal cancer, and early lung cancer to be 0.500, 
0.520, and 0.518, respectively, whereas their corresponding disability weight in the previous study 
is estimated as 0.288. We also confirm inconsistent results among stroke: long-term consequences, 
hemiplegia; stroke: long-term consequences, agnosia (or aphasia), Alzheimer’s and dementia, 
and depressive disorder. This suggests that disability weight differences are more likely to appear 
in the early and middle stages of diseases. The reason for this may be that, because in the 
beginning stages, some patients with these diseases are able to live independently, some even 
having the ability to work, ordinary citizens may be less likely to perceive the long-term health 
loss severities of these diseases. In contrast, for the same non-severe patients, nurses can evaluate 
both the medical aspect and the impact on life in general, while imagining not only the patient’s 
condition at that time, but also the deterioration in quality of life during the treatment period, the 
response rate of the treatment, and the long-term course, thus leading to higher values. Therefore, the 
results of this study are likely the more appropriate assessment of the effects of diseases.  
  Table 4 compares this study with previous representative studies by the regions they cover in 
developed and developing countries. The disability weight of disease from Japan is from the 
current study (column 1), whereas the disability weight of disease from Europe, Africa, the 
Netherlands, and Globally have been published in previous studies (Schwarzinger et al., 2003; 
Baltussen et al., 2002; van Spijker et al., 2011; Salomon et al., 2015).  
The results are as follows. First, when the disability weight is compared by different countries 
and regions, it highlights the severe loss of health caused by acute depression. For a severe case 
of depressive disorder, the disability weight is reported as 0.78 in Europe and 0.74 in the 
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Netherlands, which shows a higher loss of health than other diseases such as diabetes. In rural 
Africa, medical professionals also evaluate the disability weight of acute depression as high. In 
line with previous studies, our results also suggest developing policies that promote psychological 
well-being while preventing mental and depressive disorders and providing more aid and public 
attention to patients with such disorders. 
Second, the regional evaluation of health loss by different diseases in Europe, Japan, and Africa 
tend to be higher than the global burden disease Salomon et al. (2015). For example, the disability 
weight of diabetes is estimated at 0.385-0.452 in Japan; in Europe, it is at 0.34; in Africa, it is at 
0.34, whereas the corresponding disease is 0.02 to 0.133 (Schwarzinger et al., 2003; Baltussen et 
al., 2002; Van Spijker et al., 2011; Salomon et al., 2015). A similar tendency is found in dementia 
and strokes with long-term consequences. These differences are thought to mainly exist due to 
the respondents’ knowledge of the diseases, the capacity of the medical care system, the 
respondents’ preferences, and the estimation techniques used to measure the disability weight.        
 Table 5 displays the disability weight of diseases by different health professional groups based 
on the estimation by Salomon et al. (2015). To show heterogeneity among the medical 
professionals, age and duties of experienced nurses, which represent major demographic and 
social characters, are selected. Young or old age groups and nurse manager or non-nurse manager 
groups are established for comparison. The young group are nurses younger than or 45 years old 
whereas the old group of the respondents is older than 45 years. Columns 1, 2, 5, and 6 summarize 
the disability weights of diseases categorized by medical professionals aged 45 years or younger, 
older than 45 years, nurse manager (includes director and nurse manager), and non-nurse manager 
(includes assistant nurse manager/charge nurse, other staff, and other positions), respectively. 
Difference of disability weight between young age group and old age group is displayed in 
column 3 with the p-value in column 4, whereas the difference between chief and non-nurse 
manager group is shown in column 7 with p-value in column 8.   
  The results are summarized as follows. We found heterogenous tendency in 12 out of 17 
diseases regarding the severity of diseases between young and old health professional groups. 
The difference is obvious for non-terminal diseases. For example, the disability weight of early 
stomach cancer in the young respondent group is 0.519, whereas the corresponding weight by old 
respondent group is 0.467 (see column 1 and 2). The difference between the two groups is 0.052 
and statistically significant at 1%. It indicates that the evaluation of loss of health due to early 
stage of stomach cancer is more severe in the young respondent group. Consistent results are 
found in early colorectal cancer, early lung cancer, acute myocardial infarction, diabetes mellitus: 
without insulin injection, and Alzheimer dementia.  
This may because the older nurses have more experience in various departments or that they 
are more experienced in diseases that cause suffering. Based on these experiences, older nurses 
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may think that patients (e.g., early stomach cancer) with a severe diagnosis may be able to 
continue social life without obstacles given proper treatment in a medical center and practicing 
self-care.    
On the contrary, regarding terminal diseases, the disability weight difference between young 
and old respondent groups tends to be insignificant. Terminal diseases include stroke with long-
term consequences, agnosia (or aphasia), terminal lung cancer. Finally, the older medical 
professionals tend to evaluate severe health loss among 6 out of 17 diseases and the difference 
between the young and old groups are statistically significant at 1%. The 6 diseases are depressive 
disorder, chronic renal failure (dialysis), Dyslipidemia, high blood pressure, Diabetes mellitus 
with insulin injection, stroke with long-term consequences, and persistent consciousness disorder. 
In sum, the older medical professionals have more experience in those diseases, therefore, the 
disability weights estimated by the older group suggests a stronger policy implication for the 
government.   
  When comparing the disability weight of diseases between the nurse manager and non-nurse 
manager groups we found that disability weights are significantly different among 9 out of 17 
diseases with statistical significance at 1%. On one hand, it is worthy to note that the nurse 
managers are more likely evaluate health loss caused by mild diseases and terminal diseases with 
higher severity. For example, the mild diseases are Dyslipidemia and high blood pressure and the 
terminal diseases are terminal colorectal cancer and terminal lung cancer. On the other hand, 
nurse managers tend to estimate the loss of health by diseases between above mild and terminal 
diseases with less severity. These diseases include early stomach cancer, terminal stomach cancer, 
early colorectal cancer, Diabetes mellitus with insulin injection, and Alzheimer dementia. 
Additionally, insignificant difference between chief and non-nurse managers is observed for other 
diseases, such as early lung cancer, acute myocardial infarction, stroke with long-term 
consequences, and agnosia (or aphasia). The difference between the two groups may be because 
the nurse-manager group includes directors and nurse managers who tend to have longer nursing 
experiences than other nurses in hospitals. Moreover, in hospitals, directors are connected with 
other departments or provide counseling services to discharged patients and their families. On the 
contrary, nurse managers are supposed deepen the regular communication with patients. 
Therefore, directors or nurse managers are more likely to have a comprehensive understanding of 
the impact of end-stage cancer on patients and their families.  


















Major depression 0.498 0.78 (severe) 0.66 0.74 (severe) 
0.396 (moderate); 0.658 
(severe) 
Diabetes mellitus 0.453 (insulin); 0.385 0.34 0.34 - 
0.020 (foot) or 0.133 
(neuropathy) 








0.68 (moderate) 0.55 (paraplegia) - 
0.070 (moderate); 0.316 
(moderate with 
cognition problem); 
0.588 (severe with 
cognition problems)  




























Early stomach cancer  0.519 0.467 0.052 <0.001  0.470 0.522 -0.053 <0.001 
Terminal stomach cancer 0.588 0.576 0.012 0.022  0.570 0.599 -0.029 <0.001 
Early colorectal cancer 0.529 0.503 0.026 <0.001  0.510 0.531 -0.021 <0.001 
Terminal colorectal cancer 0.594 0.601 -0.007 0.179  0.605 0.583 0.022 <0.001 
Early lung cancer 0.531 0.517 0.015 0.008  0.515 0.520 -0.005 0.376 
Terminal lung cancer 0.593 0.595 -0.002 0.723  0.613 0.581 0.031 <0.001 
Acute myocardial infarction 0.553 0.533 0.021 <0.001  0.540 0.545 -0.006 0.310 
Stroke: long-term consequences, agnosia (or aphasia) 0.562 0.558 0.003 0.555  0.561 0.549 0.012 0.041 
Stroke: long-term consequences, hemiplegia 0.578 0.571 0.008 0.158  0.577 0.568 0.010 0.079 
Stroke: long-term consequences, persistent consciousness 
disorder 
0.577 0.595 -0.018 0.002  0.598 0.591 0.007 0.189 
Diabetes mellitus: with insulin injection  0.448 0.463 -0.015 0.006  0.443 0.461 -0.018 0.001 
Diabetes mellitus: without insulin injection 0.406 0.383 0.022 <0.001  0.388 0.395 -0.007 0.197 
High blood pressure 0.341 0.361 -0.020 <0.001  0.360 0.335 0.025 <0.001 
Dyslipidemia 0.356 0.371 -0.016 0.004  0.379 0.362 0.017 0.002 
Alzheimer dementia 0.550 0.517 0.034 <0.001  0.525 0.550 -0.025 <0.001 
Depressive disorder 0.479 0.535 -0.056 <0.001  0.513 0.505 0.008 0.160 
Chronic renal failure: dialysis 0.550 0.588 -0.038 <0.001  0.567 0.571 -0.004 0.447 






This study aims to measure the disability weights of 17 diseases in Japan using a paper-based 
questionnaire survey of medical professionals. Disability weight is a measurement of the severity 
of disability caused by a disease, where 0 equals perfect health and 1 equals death. These weights 
provide insightful evidence for policy makers, particularly regarding determining the population’s 
disability-adjusted life years to improve public welfare and health. However, previous studies 
have pointed out that the measurement of diseases’ disability weights done through surveys that 
target ordinary citizens include unclear values because ordinary citizens lack disease knowledge. 
Thus, using the same estimation approach applied in a previous ordinary-citizens-based research, 
this study entails a survey targeting veteran nurses—those with over 10 years working 
experiences and extensive knowledge—to identify the differences between the results of the two 
types of surveys. The main results of this study are summarized as follows:  
First, the disability weights found through our survey are higher than those from the survey 
targeting ordinal citizens. Importantly, the disability weights are much higher among the early- 
and middle-stage diseases in this study than the previous one. This may be because patients with 
early- or middle-stage diseases (e.g., depressive disorder, early-stage cancers) have the ability to 
live independently or even work, causing ordinary citizens to rank these diseases low on health 
loss since compared to nurses, who have extensive knowledge on the effects of these diseases 
across a wide population and over the long-term. This suggests that disability weight estimations 
based on surveys of skilled nurses may correct the underestimations of early- and middle-stage 
diseases resulting from surveys of ordinary citizens. Further, the results suggest that when the 
government measures the population disability-adjusted life years, more attention should be paid 
to non-terminal patients.  
  Second, the disability weight of early-stage cancers (e.g., lung or colorectal cancer) and 
depressive disorder are almost the same, which indicates that the severity of health loss from 
depressive disorder is the same as that of early-stage cancers. This comparison with cancers 
suggests that the patients with disabilities emanating from depressive disorder require more 
attention or aid from health organizations or the public. 
  Here, we summarize the policy implications based on the estimation results. First, our results 
show that the disability weight of early-stage of cancer is similar to the weight of depression, 
which illustrates related loss of health from acuter depression as well as cancer. Therefore, when 
the number of patients with acute depression increase, policies guiding hospitals and regions to 
provide more aid and attention to psychological well-being should be implemented. Second, the 
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disability weight of non-terminal diseases evaluated by skilled nurses is higher than the weight 
from the general public. It indicates that the government may over-evaluate the population health 
status, such as disability-adjusted life years. We recommend evaluating the status of population 
health based on the disability weight from experienced medical professionals.       
This study has two limitations. First, in this survey 21% responding rate is recorded, which may 
have caused a sample selection bias in estimating disability weight. To address this potential sample 
selection bias, future research should either increase the response rate or collect detailed data including 
the demographic or socioeconomic background of all targeted nurses. Second, because of the data 
limitation, the disability weights of seventeen representative diseases are estimated. This may not 
comprehensively cover the overall population health status (e.g., deaf). Future studies should try to 
evaluate more diseases to broaden the knowledge on disability weights.         
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The disability weights of the diseases for each participant were computed in pair comparisons 
(PC) and population health equivalence measures (PHE). In the case of the PC, we applied the 
same probit regression that was utilized in the analysis of discrete choice experimental data in 
Salomon et al. (2012). We regarded the stated choice between two diseases in a PC as the 
dependent variable. Furthermore, we treated the 17 diseases as independent variables and created 
them as dummy variables. We computed the predicted probabilities of each disease from the 
coefficient estimates of the probit regression. 
The PHE questions provide information on tradeoffs between mortality and nonfatal outcomes, 
which is needed to anchor the results from the probit regression analysis of paired comparisons 
on the (0,1) disability weight scale. Because the population health equivalence questions are 
framed in terms of a binary comparison between an intervention that averted 1000 fatalities and 
another intervention that averted some number of nonfatal outcomes, and due to paper-based 
questions rather than web-based ones, the responses provide interval-censored information rather 
than exact values. Therefore, we changed the analysis method of population health equivalence 
from Salomon et al. (2012). First, we presented the scenario as “Program A, which prevented 1000 
people from getting an illness that causes rapid death, has the same population health benefit as   ”, 
then the respondents were asked to select either “(1) less than 1000; (2) 1500; (3) 2000; (4) 3000; (5) 
5000; and (6) more than 10000” people from getting each disease. We draw the number of 





Next, we presented that Program B prevented people from being afflicted with a certain disease. 
Here, we correspond each answer in the following manner: the participants answer (B) for “less 
than 1250 persons” if they answered “less than 1000”; they answer (B) for “between 1250 persons 
and 1750 persons” when they answered 1500. Based on the formula, we make each response fit 
the PHE number. The list is as follows: 
 
 
1000 1500 2000 3000 5000 10000 0 
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Survey response Program A as 
quasi-choice 
Program B as 
quasi-choice 
Interval 
Less than 1000 None 1250 (a) 
1500 1250 1750 (b) 
2000 1750 2500 (c) 
3000 2500 4000 (d) 
5000 4000 7500 (e) 




The key idea is that we want to capture the questionees’ interval” opinions; in other words, our 
question about equivalent or approximate numbers reveal their interval of population health 








In the PHE measure, the disability weights of the diseases for each participant were estimated 
using the following formula: 1,000/final number of people in program B. For example, if a 
respondent indicates that Program (A) that averted 1000 fatalities produced equivalent or the 
closest health benefit to a Program (B) that averted 3000 cases of chronic kidney disease, then 
this response is taken to indicate that the respondent attaches a disability weight to chronic kidney 




 In sum, the table below shows each response corresponding to the quasi-choices: 
1250 1750 
3000 5000 
10000 0 2500 
2000 1500 1000 
4000 7500 






















none 45 none 1.38629436112 
1500 45 47 1.38629436112 0.287682072452 
2000 47 25 0.287682072452 -0.405465108108 
3000 25 14 -0.405465108108 -1.098612288668 
5000 14 215 -1.098612288668 -1.871802176902 
More than 
10000 
215 none -1.871802176902 none 
 
After the PC and PHE statistical analyses, we rescale the probit coefficients obtained by PC 
since the probit regression of PC responses yields values that are on an arbitrary scale with 
constant variance across health states. For this, we completed two steps. The first step was to run 
a linear regression of the probit coefficients from the pooled analysis of the disability weight 
estimates (these were derived from a maximum likelihood estimation of the PHE responses). The 
regression resulted in an estimated slope and intercept for a linear transformation of the probit 
coefficients onto the (logit) disability-weight scale. The second step was to use numerical 
integration to obtain mean estimates of disability weights on the natural 0-to-1scale. First, we 
simulated normal random variates onto the logit scale with means defined by the rescaled probit 
coefficients and variance defined by the overall standard deviation of these coefficients across 
survey-specific estimates. Next, we transformed each of these simulated values through an 
inverse-logit function. Finally, we computed the mean across the resulting values for each health 
state. 
 
 
 
 
